Poor
Not Aligned
Patient Risk:
Moderate
Summary
The AI claim about SUTAB’s active ingredients is contradicted by the provided label excerpt, which lists sodium sulfate, magnesium sulfate, and potassium chloride (not potassium sulfate).
Category Scores
Accurate Statements
Unsupported Statements
Contradictions
High
AI Statement
Sutab’s generic (active ingredient) name is sodium sulfate, potassium sulfate, and magnesium sulfate.
Label Reference
SECTION 3 (Dosage Forms and Strengths): “Tablets: 1.479 g sodium sulfate, 0.225 g magnesium sulfate, and 0.188 g potassium chloride.”
Important Omissions
The claim should have included potassium chloride (per label) rather than potassium sulfate.
Importance:
High
Safety Assessment
Potential Patient Risk:
Moderate
Incorrect active-ingredient identification could lead to misunderstanding of the product’s composition and related safety considerations, even though the claim itself is purely about ingredient naming.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Active ingredient composition is incorrect (potassium sulfate stated instead of potassium chloride).
Suggested Improvement
Revise the claim to match the label: sodium sulfate, magnesium sulfate, and potassium chloride.